marcellomycin has been researched along with Bone Marrow Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crespeigne, N; de Marneffe, M; Dodion, P; Kenis, Y; Lenaz, L; Nicaise, C; Piccart, M; Rozencweig, M; Sculier, JP | 1 |
| Brunner, KW; Cavalli, F; Goldhirsch, A; Joss, RA; Kaplan, S; Varini, M | 1 |
2 other study(ies) available for marcellomycin and Bone Marrow Diseases
| Article | Year |
|---|---|
Clinical phase I trial of marcellomycin with a single-dose schedule.
Topics: Adult; Aged; Anthracyclines; Antibiotics, Antineoplastic; Bone Marrow Diseases; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Naphthacenes; Neoplasms | 1983 |
A phase I trial of marcellomycin with a weekly dose schedule.
Topics: Adult; Aged; Anthracyclines; Antibiotics, Antineoplastic; Bone Marrow Diseases; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Naphthacenes; Neoplasms; Thrombocytopenia | 1983 |